Skip to main content

Avestar Capital, LLC

Position in AMGN — Amgen Inc

CIK 1704404 New York, NY

Position in AMGN

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$1,295,303
+$62,773 QoQ
Shares Held
3,577
+2.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,526
of 3,140 holders
Holding Since
Dec 2022
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMGN Over Time

Shares Held

Position Value (USD)

Derivatives in AMGN

reported options exposure · as of Sep 30, 2025
CallValue
$56,440
CallShares
200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Avestar Capital, LLC holds $29,224,901 across 12 Drug Manufacturers - General names. AMGN ranks #7 (4.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 AMGN
Amgen Inc
This page
3,577 $1,295,303

All Filings in AMGN

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,295,303 3,577
2026-03-31 $1,232,530 3,503
2025-12-31 $1,124,309 3,435
2025-09-30 $56,440 200
2025-09-30 $908,966 3,221
2025-06-30 $1,098,970 3,936
2025-03-31 $1,659,938 5,328
2024-12-31 $1,193,731 4,580
2024-09-30 $1,472,499 4,570
2024-06-30 $1,320,413 4,226
2024-03-31 $737,810 2,595
2023-12-31 $591,017 2,052
2023-09-30 $347,237 1,292
2022-12-31 $227,971 868